Skip to main content
. 2017 Sep 25;2017:9845175. doi: 10.1155/2017/9845175

Figure 1.

Figure 1

Evaluation of GA, FGF-23, and sRAGE levels in CKD-G5D patients. GA levels (a) and sRAGE (c) were higher in DM CKD-G5D patients than in non-DM CKD-G5D patients (∗∗∗p < 0.001 and p < 0.05, resp.). FGF-23 levels (b) were the same in the two groups.